MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/20/1433/001  Fluad Tetra   
--¹ 
EU/1/20/1433/002  Fluad Tetra   
--¹ 
EU/1/20/1433/003  Fluad Tetra   
--¹ 
EU/1/20/1433/004  Fluad Tetra   
--¹ 
Suspension for 
injection 
Suspension for 
injection 
Suspension for 
injection 
Suspension for 
injection 
Intramuscular use  pre-filled syringe 
0.5 ml 
1 pre-filled syringe  
(glass) with 
needle 
Intramuscular use  pre-filled syringe 
0.5 ml 
1 pre-filled syringe  
(glass) without 
needle 
Intramuscular use  pre-filled syringe 
0.5 ml 
(glass) with 
needle 
Intramuscular use  pre-filled syringe 
0.5 ml 
(glass) without 
needle 
10 pre-filled 
syringes  
10 pre-filled 
syringes  
--¹  Each 0.5 ml dose contains: 
Influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains*: 
A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022 IVR-238)                              15 µg HA** 
A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/6/2021 IVR-227)                                                    15 µg HA** 
B/Austria/1359417/2021-like strain (B/Austria/1359417/2021 BVR-26)                                           15 µg HA** 
B/Phuket/3073/2013-like strain (B/Phuket/3073/2013 BVR-1B)                                                      15 µg HA**  
per 0.5 ml dose 
*propagated in fertilized hens’ eggs from healthy chicken flocks and adjuvanted with MF59C.1 
** haemagglutinin 
 
 
 
  
 
 
 
 
 
 
 
